Balchem says Thailand FDA approves OptiMSM ingredient
Share
Listen to the news
Balchem says Thailand FDA approves OptiMSM ingredient
  • Balchem secured Thailand FDA approval for OptiMSM, expanding regulatory clearance for its branded methylsulfonylmethane ingredient.
  • Approval supports broader product development options in sports nutrition, with OptiMSM positioned for exercise recovery applications.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Balchem Corporation published the original content used to generate this news brief on April 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending